GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 9,870.00
-270.00 (-2.66%)
Oct 8, 2026, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 233.43 billion as of October 8, 2026. It is the 21,775th most valuable company in the world and the 795th biggest in South Korea. Its market cap has increased by 34.65% in one year.
Market Cap
233.43B
Enterprise Value
195.16B
Revenue
32.64B
Global Rank
Country Rank
#795 South Korea
PE Ratio
42.95
ChartMarket Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 233.43B, a decrease of -11.08%. That is a compound annual growth rate of -8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 233.43B | 44.72% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medy-Tox | 430.12B |
| MEDIPOST | 379.52B |
| SillaJen | 326.99B |
| Genomictree | 299.45B |
| Bioneer | 228.68B |
| GC Cell | 223.15B |
| HLB Therapeutics | 217.70B |
| NeoImmuneTech | 196.25B |